KLK3

KLK3 (PSA) is an androgen-regulated serine protease whose physiological role centers on semen coagulum liquefaction through hydrolysis of semenogelin substrates, a function shaped by adaptive evolution across primates (PMID:23204305, PMID:39878341). Its transcription is driven by androgen receptor (AR) binding to androgen response elements in the proximal promoter; the G-158A SNP within AREI increases AR binding affinity and amplifies the androgen-induced transcriptional response, with the A allele conferring enhanced expression (PMID:17151093). AR-mediated transactivation at the KLK3 locus is potentiated by the MRGBP–MRG15–TIP60 epigenetic complex, which is recruited to H3K4me1/3-marked AR binding regions where TIP60 acetylates histone variant H2A.Z, increasing AR occupancy and KLK3 expression (PMID:30076933). KLK3 transcription is additionally driven downstream of TRβ signaling, alongside other AR target genes. At the protein level, the proteolytic activity of KLK3 is modulable by exogenous synthetic cyclic peptides that bind the protease domain and stimulate catalysis, with a disulfide bridge between terminal cysteines required for stimulatory activity (PMID:18627344, PMID:19967419). Comparative enzymatic analysis of recombinant primate orthologs shows that catalytic efficiency has been tuned during evolution, with chimpanzee KLK3 exhibiting higher velocity and efficiency than human KLK3 (PMID:39878341). An unusual alternatively spliced product, PSA-LM, sharing only the signal peptide with canonical PSA, is also expressed in prostatic secretory epithelium under androgen regulation (PMID:11834722).

1. 2002 Medium

   Establishing that the KLK3 locus produces more than the canonical protease, alternative splicing was shown to generate a distinct androgen-regulated protein, broadening the locus's output beyond PSA itself.

   Evidence RT-PCR, cDNA cloning, immunohistochemistry, and androgen stimulation in prostatic epithelial cells

   PMID:11834722

   Open questions at the time

   • Function of the PSA-LM product is undefined
   • No enzymatic or interaction characterization of PSA-LM
2. 2006 Medium

   To explain why a common promoter polymorphism affects PSA levels, the G-158A SNP within AREI was shown to functionally increase AR binding and androgen-driven transcription, mechanistically linking genotype to expression.

   Evidence EMSA for AR binding and reporter assay for androgen response

   PMID:17151093

   Open questions at the time

   • Effect measured in reporter systems, not endogenous chromatin
   • Population-level consequences not addressed in this finding
3. 2008 Medium

   Addressing whether KLK3 catalytic activity is pharmacologically tractable, synthetic cyclic peptides were shown to specifically stimulate KLK3 proteolysis in vitro, establishing exogenous modulation of the protease domain.

   Evidence In vitro peptide-binding and enzymatic activity assays with cyclized peptides

   PMID:18627344

   Open questions at the time

   • Mechanism of stimulation at the structural level not resolved
   • In vivo relevance of peptide activation not tested
4. 2009 Medium

   Refining the activating peptide chemistry, structure-activity work identified the disulfide bridge as required for stimulatory activity and produced a more stable cyclization mimic, clarifying the determinants of KLK3 activation.

   Evidence Peptide analogue synthesis, in vitro KLK3 enzymatic activity, and plasma stability assays

   PMID:19967419

   Open questions at the time

   • No co-structure of peptide bound to KLK3
   • Therapeutic utility not demonstrated
5. 2012 Low

   Two complementary studies probed the SNP mechanism and evolutionary context: simulation rationalized how the A allele stabilizes AR homodimer binding, while comparative genomics implicated sperm-competition-driven coevolution of KLK3 with semenogelin substrates.

   Evidence Molecular dynamics simulation of the -158 AREI element; dN/dS and phylogenetic analysis across 22 primate species

   PMID:22877366 PMID:23204305

   Open questions at the time

   • Both findings are computational without experimental validation in these papers
   • Predicted catalytic-spectrum expansion not biochemically tested here
6. 2018 Medium

   To define the chromatin machinery enabling AR transactivation, MRGBP was shown to bridge MRG15 and TIP60 at H3K4-methylated AR binding regions, driving H2A.Z acetylation and increased AR occupancy and KLK3 expression.

   Evidence Co-IP, ChIP, knockdown/overexpression, and histone modification analysis

   PMID:30076933

   Open questions at the time

   • Generality of this complex across other AR targets not fully established
   • Direct causal link between H2A.Z acetylation and AR loading not isolated
7. 2025 High

   Resolving whether evolutionary sequence change altered KLK3 enzymology, recombinant primate orthologs and ancestral reconstruction directly measured catalytic differences, showing chimpanzee KLK3 is more efficient than human and that chimeric KLK2/KLK3 enzymes arose independently in some apes.

   Evidence Recombinant protein production, in vitro enzymatic kinetics, and ancestral sequence reconstruction

   PMID:39878341

   Open questions at the time

   • In vivo consequence of kinetic differences for reproductive fitness not directly demonstrated
   • Substrate specificity beyond bulk kinetics not fully mapped
8. 2025 Medium

   Extending the transcriptional regulation of KLK3, TRβ signaling was shown to drive AR target gene expression including KLK3, with a TRβ antagonist downregulating AR and reducing tumor growth.

   Evidence In vitro proliferation, xenograft model, and KLK3 expression readout (preprint)

   Open questions at the time

   • Preprint not peer-reviewed
   • Direct vs AR-mediated effect on KLK3 promoter not dissected

• How KLK3 proteolytic activity is regulated in vivo and how the locus's alternative products contribute to prostate physiology and cancer remain unresolved.
• No endogenous physiological activator/inhibitor of KLK3 protease defined
• Function of PSA-LM unknown
• Structural basis of peptide stimulation unresolved